Sarepta Therapeutics Inc (NASDAQ:SRPT)

140.33
Delayed Data
As of Jun 22
 -9.32 / -6.23%
Today’s Change
32.36
Today|||52-Week Range
176.50
+152.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues35.0M46.0M57.3M64.6M
 
 
 
 
 
Cost of Goods Sold534.0K1.3M1.6M3.5M
 
 
 
 
 
Depreciation And Amortization1.8M2.6M2.1M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income32.7M42.1M53.5M58.8M
 
 
 
 
 
General Expenses90.7M62.4M76.4M89.5M
 
 
 
 
 
Research And Development58.8M34.2M44.4M46.2M
 
 
 
 
 
Total Operating Expenses93.0M66.3M80.2M95.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-58.0M-20.3M-22.9M-30.7M
 
 
 
 
 
Extraordinary Charge-5.4M-25.6M-247.0K0.00
 
 
 
 
Interest Expense On Debt----2.7M7.6M
 
 
 
Other Expenses184.0K184.0K0.0018.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-63.2M-45.7M-25.8M-35.2M
 
 
 
 
 
Income Taxes-109.0K-2.0M-1.8M-139.0K
 
 
 
 
 
Net Income-63.0M-47.7M-24.0M-35.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.0M61.5M64.3M64.6M
 
 
 
 
 
Shares To Calculate EPS Diluted55.0M61.5M64.3M64.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.15-$0.78-$0.37-$0.55
 
 
 
 
 
EPS Diluted-$1.15-$0.78-$0.37-$0.55